| Literature DB >> 27775663 |
Hongtao Guo1, Xuyan Niu2, Yan Gu3,4, Cheng Lu5,6, Cheng Xiao7,8, Kevin Yue9, Ge Zhang10, Xiaohua Pan11, Miao Jiang12, Yong Tan13,14, Hongwei Kong15, Zhenli Liu16, Guowang Xu17, Aiping Lu18,19,20.
Abstract
Pattern classification is a key approach in Traditional Chinese Medicine (TCM), and it is used to classify the patients for intervention selection accordingly. TCM cold and heat patterns, two main patterns of rheumatoid arthritis (RA) had been explored with systems biology approaches. Different regulations of apoptosis were found to be involved in cold and heat classification in our previous works. For this study, the metabolic profiling of plasma was explored in RA patients with typical TCM cold or heat patterns by integrating liquid chromatography/mass spectrometry (LC/MS) and gas chromatography/mass spectrometry (GC/MS) platforms in conjunction with the Ingenuity Pathway Analysis (IPA) software. Three main processes of metabolism, including amino acid, carbohydrate and lipid were focused on for function analysis. The results showed that 29 and 19 differential metabolites were found in cold and heat patterns respectively, compared with healthy controls. The perturbation of amino acid metabolism (increased essential amino acids), carbohydrate metabolism (galactose metabolism) and lipid metabolism, were found to be involved in both cold and heat pattern RA. In particular, more metabolic perturbations in protein and collagen breakdown, decreased glycolytic activity and aerobic oxidation, and increased energy utilization associated with RA cold pattern patients. These findings may be useful for obtaining a better understanding of RA pathogenesis and for achieving a better efficacy in RA clinical practice.Entities:
Keywords: Traditional Chinese Medicine; cold pattern; heat pattern; metabolic pathways; rheumatoid arthritis
Mesh:
Substances:
Year: 2016 PMID: 27775663 PMCID: PMC5085781 DOI: 10.3390/ijms17101757
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Comparison of cold pattern vs. healthy control and heat pattern vs. healthy control in amino acids metabolism (↑, upregulation, ↓, downregulation, N.S, no significance).
| No. | Pathway | Molecules | Cold Pattern vs. Healthy Control | Heat Pattern vs. Healthy Control | ||||
|---|---|---|---|---|---|---|---|---|
| Fold | Regulations | Fold | Regulations | |||||
| 1 | Aminoacyl-tRNA biosynthesis | 1.11 | ↑ | 5.94 × 10−7 | 1.11 | ↑ | 4.21 × 10−8 | |
| N.S | N.S | 1.25 | ↑ | |||||
| 1.11 | ↑ | 1.25 | ↑ | |||||
| 1.25 | ↑ | 1.25 | ↑ | |||||
| 2.5 | ↓ | N.S | N.S | |||||
| 2 | Valine, leucine and isoleucine biosynthesis | 1.11 | ↑ | 1.87 × 10−4 | 1.11 | ↑ | 1.54 × 10−7 | |
| N.S | N.S | 1.25 | ↑ | |||||
| 1.25 | ↑ | 1.25 | ↑ | |||||
| 3 | Urea cycle and metabolism of amino groups | 2.5 | ↓ | 1.31 × 10−3 | N.S | N.S | N.S | |
| Urea | 1.3 | ↓ | N.S | N.S | N.S | |||
| 4 | Alanine and aspartate metabolism | 1.2 | ↓ | 1.50 × 10−3 | 1.4 | ↓ | 3.21 × 10−2 | |
| Citric acid | 1.3 | ↓ | N.S | N.S | ||||
| 5 | Valine, leucine and isoleucine degradation | 1.11 | ↑ | 3.26 × 10−3 | 1.11 | ↑ | 1.23 × 10−5 | |
| N.S | N.S | 1.25 | ↑ | |||||
| 1.25 | ↑ | 1.25 | ↑ | |||||
| 6 | Glycine, serine and threonine metabolism | 3.5 | ↓ | 4.96 × 10−3 | 2.9 | ↓ | 1.53 × 10−3 | |
| 1.11 | ↑ | 1.25 | ↑ | |||||
| 7 | Arginine and proline metabolism | 2.5 | ↓ | N.S | N.S | N.S | ||
| Urea | 1.3 | ↓ | N.S | N.S | N.S | |||
| 8 | Glutamate metabolism | Citric acid | 1.3 | ↓ | 5.91 × 10−2 | N.S | N.S | N.S |
Comparison of cold pattern vs. healthy control and heat pattern vs. healthy control in carbohydrates metabolism (↑, upregulation, ↓, downregulation, N.S, no significance).
| No. | Pathway | Molecules | Cold Pattern vs. Healthy Control | Heat Pattern vs. Healthy Control | ||||
|---|---|---|---|---|---|---|---|---|
| Fold | Regulations | Fold | Regulations | |||||
| 1 | Glyoxylate and dicarboxylate metabolism | Citric acid | 1.3 | ↓ | 9.38 × 10−4 | N.S | N.S | N.S |
| 3.5 | ↓ | 2.9 | ↓ | 2.55 × 10−2 | ||||
| 2 | Galactose metabolism | myo-inositol | 1.5 | ↓ | 1.80 × 10−3 | 1.5 | ↓ | 3.52 × 10−2 |
| 1.4 | ↓ | N.S | N.S | |||||
| 3 | Inositol metabolism | myo-inositol | 1.5 | ↓ | 1.02 × 10−2 | 1.5 | ↓ | 5.77 × 10−3 |
| 4 | Citrate cycle | Citric acid | 1.3 | ↓ | 4.48 × 10−2 | N.S | N.S | N.S |
| 5 | Pentose phosphate pathway | 1.4 | ↓ | 4.39 × 10−2 | N.S | N.S | N.S | |
| 6 | Propanoate metabolism | 1.25 | ↑ | 7.57 × 10−2 | 1.25 | ↑ | 4.33 × 10−2 | |
| 7 | Starch and sucrose metabolism | 1.4 | ↓ | 8.18 × 10−2 | N.S | N.S | N.S | |
| 8 | Glycolysis/gluconeogenesis | 1.4 | ↓ | 9.38 × 10−2 | N.S | N.S | N.S | |
Comparison of cold pattern vs. healthy control and heat pattern vs. healthy control in lipid metabolism (↓, downregulation, N.S, no significance).
| No. | Pathway | Molecules | Cold Pattern vs. Healthy Control | Heat Pattern vs. Healthy Control | ||||
|---|---|---|---|---|---|---|---|---|
| Fold | Regulations | Fold | Regulations | |||||
| 1 | Fatty acid biosynthesis | Palmitic acid | 1.2 | ↓ | 1.76 × 10−2 | N.S | N.S | N.S |
| 2 | Fatty acid elongation in mitochondria | Palmitic acid | 1.2 | ↓ | 4.12 × 10−2 | N.S | N.S | N.S |
| 3 | Biosynthesis of steroids | cholesterol | 1.2 | ↓ | 5.2 × 10−2 | N.S | N.S | N.S |
| 4 | C21-steroid hormone metabolism | cholesterol | 1.2 | ↓ | 5.2 × 10−2 | N.S | N.S | N.S |
| 5 | Linoleic acid metabolism | Linoleic Acid | 1.2 | ↓ | 6.43 × 10−2 | N.S | N.S | N.S |
| 6 | Bile acid metabolism | Linoleic Acid | 1.2 | ↓ | 7.4 × 10−2 | N.S | N.S | N.S |
| 7 | Glycerolipid metabolism | 3.5 | ↓ | 9.8 × 10−2 | 2.9 | ↓ | 5.64 × 10−2 | |
| 8 | Fatty acid metabolism | Palmitic acid | 1.2 | ↓ | 1.28 × 10−1 | N.S | N.S | N.S |
| 9 | Inositol phosphate metabolism | myo-inositol | 1.5 | ↓ | 1.44 × 10−1 | 1.5 | ↓ | 8.4 × 10−2 |
Figure 1An overview of metabolic imbalances in rheumatoid arthritis (RA) patients with cold and heat patterns. A schematic representation of amino acid, carbohydrate and lipid metabolism in the center, showing representative metabolite changes connected to the cold pattern and heat pattern of RA patients. The direction of the arrows represents the regulation direction of metabolites; the red arrows represent metabolites in heat pattern RA compared to healthy controls; the blue arrows represent metabolites in cold pattern RA compared to healthy controls. The textboxes outside the molecules represent different types of metabolic pathways: green represents amino acid metabolism; red represents carbohydrate metabolism; and black represents lipid metabolism.
Clinical characteristics baseline of rheumatoid arthritis (RA) patients with cold and heat patterns.
| Item | RA with Cold Pattern ( | RA with Heat Pattern ( |
|---|---|---|
| Age, mean (S.D.), years | 46.7 (9.7) | 42.0 (1.7) |
| RA disease duration, mean (S.D.), years | 1.5 (0.9) | 1.3 (1.1) |
| ESR, mean (S.D.), mm/h | 20.2 (10.3) | 21.5 (9.6) |
| RF, positive, | 14 (50) | 16 (55.2) |
| DAS28-ESR, mean (S.D.) | 2.3 (0.6) | 2.3 (0.5) |
| Anti-CCP, positive, | 19 (67.9) | 21 (72.4) |
RA, rheumatoid arthritis; S.D., standard deviation; ESR, erythrocyte sedimentation rate; RF, rheumatoid factor; CCP, cyclic citrullinated peptide.